Lees K R, Meredith P A, Reid J L
University Department of Materia Medica, Stobhill General Hospital, Glasgow, Scotland.
J Cardiovasc Pharmacol. 1987;10 Suppl 10:S105-7.
A double-blind, randomised, placebo-controlled, latin square design study of nifedipine, 20 mg, and lisinopril, 20 mg, alone and in combination was performed in 12 healthy male volunteers. Blood pressure, heart rate, lisinopril and nifedipine levels, plasma catecholamines, renin, aldosterone, and angiotensin converting enzyme activity were measured for 96 h after each acute dose. Both drugs lowered blood pressure (p less than 0.001), but the combination showed only additive effects. Heart rate rose over the first 4 h following the combination. Side effects were also additive. There was no effect of nifedipine on plasma ACE, renin, or aldosterone and no effect of either drug on plasma catecholamines. The pharmacokinetics of both drugs were unaltered in combination. Thus, nifedipine and lisinopril have additive dynamic effects with no pharmacokinetic interaction.
在12名健康男性志愿者中进行了一项采用双盲、随机、安慰剂对照、拉丁方设计的研究,分别给予硝苯地平20毫克、赖诺普利20毫克单独用药及联合用药。在每次急性给药后96小时测量血压、心率、赖诺普利和硝苯地平水平、血浆儿茶酚胺、肾素、醛固酮及血管紧张素转换酶活性。两种药物均降低了血压(p<0.001),但联合用药仅显示相加作用。联合用药后最初4小时内心率升高。副作用也是相加的。硝苯地平对血浆ACE、肾素或醛固酮无影响,两种药物对血浆儿茶酚胺均无影响。联合用药时两种药物的药代动力学均未改变。因此,硝苯地平和赖诺普利具有相加的动力学效应,且无药代动力学相互作用。